儿童巨大横纹肌样脑膜瘤伴胚系BAP1致病性变异:一例罕见临床病例
本文报告一例儿童右侧小脑幕横纹肌样脑膜瘤,侵犯包括右颈静脉在内的多支静脉结构,先后接受5次手术;病理均符合横纹肌样脑膜瘤,但活检及首次开颅组织缺乏后续切除标本中的高级别特征;基因分析发现BAP1双等位基因缺失,外周血证实为致病性BAP1变异胚系携带者。
要点
- 儿童横纹肌样脑膜瘤罕见,局部复发率高,全切除需与术后神经功能缺损风险平衡。
- 本例初似低级别脑膜瘤伴横纹肌样特征,复发后转化为世界卫生组织III级横纹肌样脑膜瘤。
- 基因检测发现BAP1双等位基因缺失,外周血证实胚系BAP1致病性变异。
核心结论
- 横纹肌样脑膜瘤在儿童中罕见且局部复发率高。
- 全切除需与术后神经功能缺损风险相平衡。
- 应对这一罕见病变进行基因检测以识别遗传性胚系突变。
研究设计与样本
- 本文为单例儿童病例报告,描述其临床表现、5次手术治疗经过、病理及基因检测结果。
主要发现
- 患儿为右侧小脑幕横纹肌样脑膜瘤,侵犯包括右颈静脉在内的多支静脉结构。
- 首次手术为颅内肿瘤减容及静脉结构重建,术后未能拔除脑室导管并接受脑室腹腔分流。
- 第二次开颅术前影像发现颅内肿瘤显著复发,术后磁共振显示显著残留肿瘤。
- 第三次开颅行肿瘤全切除并重建上矢状窦,术后无新发神经功能缺损。
- 最终手术由耳鼻喉科与心胸外科联合切除颈胸部残留肿瘤,打开颈静脉并切除内膜残留肿瘤。
关键数值与推荐
- 所有手术病理均符合横纹肌样脑膜瘤,但活检及首次开颅组织缺乏后续切除标本中的高级别特征。
- 基因分析发现BAP1两个抑癌基因均缺失,外周血检测显示患者为致病性BAP1变异的胚系携带者。
- BAP1胚系突变相关癌症综合征涉及葡萄膜与皮肤黑色素瘤、恶性间皮瘤、非典型Spitz肿瘤及透明细胞肾细胞癌。
- 携带该突变的患者被鼓励自11岁起每年进行眼科检查。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rhabdoid meningiomas are rare World Health Organization grade 3 tumors that tend to follow an aggressive course, with an increased likelihood for local recurrence, remote metastasis, and cerebrospinal fluid dissemination. Genetic testing has found certain genes associated with reduced time to tumor recurrence. BAP1 (BRCA1-associated protein 1) is a tumor suppressor gene that is associated with multiple tumors, including rhabdoid meningiomas. CASE DESCRIPTION: We present a case of a pediatric patient who presented with a rhabdoid meningioma occurring in the right tentorium and invading multiple venous structures, including the right jugular vein. The patient underwent 5 separate operations for management of this tumor. The first surgery was an intracranial tumor debulking with reconstruction of venous structures. Postoperatively, the patient was unable to have the ventricular catheter removed and underwent placement of a ventriculoperitoneal shunt. Significant recurrence of the intracranial portion of tumor was found during preoperative imaging for her second stage procedure. She underwent a second craniotomy for resection of the tumor. Her postoperative magnetic resonance imaging showed significant residual tumor and the patient therefore underwent a third craniotomy for total tumor resection, which involved reconstruction of the superior sagittal sinus. She did well after this surgery, with no new neurologic deficits. Her final operation involved resection of the residual tumor in the neck and chest by both otolaryngology and cardiothoracic surgery. This surgery involved opening the jugular vein and resecting residual tumor from the intima. Pathologic results from all surgeries were consistent with rhabdoid meningioma; however, the tissue from the biopsy and first craniotomy lacked the high-grade features that were found on subsequent resections. Genetic analysis found loss of both BAP1 tumor suppressor genes. Peripheral blood testing showed that this patient was a germline carrier of a pathogenic BAP1 variant. DISCUSSION: Pediatric rhabdoid meningiomas represent a rare disease and are found on recurrent tumors in conjunction with lower-grade meningioma disease. Our patient presented with what was initially believed to be a low-grade meningioma with rhabdoid features, which then transformed into a World Health Organization grade III rhabdoid meningioma on recurrence. This tumor was discovered to have a biallelic loss of BAP-1 mutation and the patient was found to have a germline mutation in 1 of her BAP-1 alleles. Germline mutations in BAP-1 are associated with a cancer syndrome that involves uveal and cutaneous melanoma, malignant mesothelioma, atypical Spitz tumors, and clear-cell renal cell carcinoma. Patients with this mutation are encouraged to undergo annual eye examinations starting at the age of 11 years. The BAP-1 tumor predisposition syndrome is most commonly an inherited mutation associated with incomplete penetrance and variation with nonoverlapping tumor types. CONCLUSIONS: Rhabdoid meningiomas are unlikely to be found in children and have a high rate of local recurrence. Gross total resection has to be balanced with risk of postoperative deficit. Genetic testing of this rare entity should be performed to identify any hereditary germline mutations.
引用
- Ravanpay AC, Barkley A, White-Dzuro GA, et al. Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case. World Neurosurg. 2018. PMID: 29981911. doi:10.1016/j.wneu.2018.06.227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。